Stocks in Concern on New Development: Costco Wholesale (NASDAQ:COST), Zumiez, Inc. (NASDAQ:ZUMZ)

Shares of Costco Wholesale Corporation (NASDAQ:COST) [Trend Analysis] runs in leading trade, it surging 1.09% to traded at $151.74. The firm has price volatility of 1.10% for a week and 1.42% for a month. Its beta stands at 0.86 times. Costco Wholesale Corp. (COST) revealed that its total same sales for the month of November 2016 surged 1 percent, with a 1 percent raise in U.S., a 1 percent rise in Canada, and Other International same sales declined 2 percent.

Monthly Same sales, not comprising the impacts from changes in gasoline prices and foreign exchange, were up 2 percent, with a 1 percent rise in U.S., a 3 percent raise in Canada, and 4 percent rise in Other International same sales. Net sales of $9.95 billion for the month of November, the four weeks ended November 27, 2016, an raise of three percent from $9.68 billion during the same period previous year.

For the twelve-week first quarter ended November 20, 2016, the Firm reported net sales of $27.47 billion, an raise of three percent from $26.63 billion during the first quarter previous year. Quarterly total same sales surged 1 percent, while Same sales, not comprising certain items, surged 2 percent. Narrow down four to firm performance, its weekly performance was 0.09% and monthly performance was 3.78%. The stock price of COST is moving up from its 20 days moving average with 1.76% and isolated positively from 50 days moving average with 1.48%.

Zumiez, Inc. (NASDAQ:ZUMZ) [Trend Analysis] luring active investment momentum, shares a decrease -1.01% to $24.55. Zumiez Inc. (NASDAQ: ZUMZ) reported that results for the third quarter ended October 29, 2016. Rick Brooks, Chief Executive Officer of Zumiez Inc., stated, “Our monthly same sales trend turned positive in September driven by a solid back-to-school selling season and continued to accelerate as the third quarter progressed. We are happy with the raise in our top-line which included positive growth in our men’s, accessories, and junior’s categories.”

“Looking ahead, we believe that our current merchandise offering has us positioned to continue with strong results during the important holiday season. That stated, we are proceeding prudently and managing expenses tightly in light of the headwinds presently facing the retail industry. Our primary focus remains on executing our strategic multi-year growth objectives and delivering surged shareholder value over the long-term.”

The total volume of 683867 shares held in the session was surprisingly higher than its average volume of 474.24 shares. EPS anticipates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -29.50%, and looking additional price to next year’s EPS is 22.05%. While take a short look on price to sales ratio, that was 0.76 and price to earnings ratio of 32.86 attracting passive investors.

 

About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *